Cargando…
Potential of plants to produce recombinant protein products
Plants have great potential as photosynthetic factories to produce pharmaceutically important and commercially valuable biomedicines and industrial proteins at low cost. The U.S. Food and Drug Administration (U.S. FDA) has approved the drug Elelyso (taliglucerase alfa) produced by carrot cells for t...
Autores principales: | Park, Ky Young, Wi, Soo Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101786/ https://www.ncbi.nlm.nih.gov/pubmed/32288513 http://dx.doi.org/10.1007/s12374-016-0482-9 |
Ejemplares similares
-
Gene Delivery into Plant Cells for Recombinant Protein Production
por: Chen, Qiang, et al.
Publicado: (2015) -
Plant-made pharmaceuticals: exploring studies for the production of recombinant protein in plants and assessing challenges ahead
por: Lee, Juho, et al.
Publicado: (2023) -
Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins
por: Schillberg, Stefan, et al.
Publicado: (2019) -
Maximizing the Production of Recombinant Proteins in Plants: From Transcription to Protein Stability
por: Feng, Ziru, et al.
Publicado: (2022) -
Functional switching of NPR1 between chloroplast and nucleus for adaptive response to salt stress
por: Seo, So Yeon, et al.
Publicado: (2020)